IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [21] ABSORPTION ENHANCERS IN NASAL INSULIN DELIVERY AND THEIR INFLUENCE ON NASAL CILIARY FUNCTIONING
    SCHIPPER, NGM
    VERHOEF, J
    ROMEIJN, SG
    MERKUS, FWHM
    JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) : 173 - 185
  • [22] Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies
    Sintov, Amnon C.
    Levy, Haim V.
    Botner, Shafir
    JOURNAL OF CONTROLLED RELEASE, 2010, 148 (02) : 168 - 176
  • [23] Efficacy of pulmonary insulin delivery in diabetic rats: Use of a model-based approach in the evaluation of insulin powder formulations
    Amidi, Maryam
    Krudys, Kevin M.
    Snel, Cor J.
    Crommelin, Daan J. A.
    Della Pasqua, Oscar E.
    Hennink, Wim E.
    Jiskoot, Wim
    JOURNAL OF CONTROLLED RELEASE, 2008, 127 (03) : 257 - 266
  • [24] Influence of deposition and spray pattern of nasal powders on insulin bioavailability
    Pringels, E
    Callens, C
    Vervaet, C
    Dumont, F
    Slegers, G
    Foreman, P
    Remon, JP
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 310 (1-2) : 1 - 7
  • [25] THE EFFECT OF SOYBEAN-DERIVED STEROL AND ITS GLUCOSIDE AS AN ENHANCER OF NASAL ABSORPTION OF INSULIN IN RABBITS IN-VITRO AND IN-VIVO
    MAITANI, Y
    YAMAMOTO, T
    TAKAYAMA, K
    NAGAI, T
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (02) : 129 - 137
  • [26] Current Therapeutic Strategy in the Nasal Delivery of Insulin: Recent Advances and Future Directions
    Chen, Jiawei
    Hu, Liandong
    Yang, Guang
    Hu, Qiaofeng
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (05) : 400 - 415
  • [27] Nasal delivery of insulin using bioadhesive chitosan gels
    Varshosaz, J
    Sadrai, H
    Heidari, A
    DRUG DELIVERY, 2006, 13 (01) : 31 - 38
  • [28] Lipid emulsions as vehicles for enhanced nasal delivery of insulin
    Mitra, R
    Pezron, I
    Chu, WA
    Mitra, AK
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 205 (1-2) : 127 - 134
  • [29] IN-VITRO AND IN-VIVO ANALYSIS OF COLON SPECIFICITY OF CALCIUM PECTINATE FORMULATIONS
    RUBINSTEIN, A
    RADAI, R
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1995, 41 (05) : 291 - 295
  • [30] NASAL INSULIN DELIVERY WITH DIMETHYL-BETA-CYCLODEXTRIN AS AN ABSORPTION ENHANCER IN RABBITS - POWDER MORE EFFECTIVE THAN LIQUID FORMULATIONS
    SCHIPPER, NGM
    ROMEIJN, SG
    VERHOEF, JC
    MERKUS, FWHM
    PHARMACEUTICAL RESEARCH, 1993, 10 (05) : 682 - 686